Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Ovarian Neoplasms 2Lung Neoplasms 2Carcinoma, Ovarian Epithelial 2Carcinoma, Non-Small-Cell Lung 2Breast Neoplasms 2Urinary Bladder Neoplasms 1Tongue Neoplasms 1Oropharyngeal Neoplasms 1Oligodendroglioma 1Mouth Neoplasms 1Locally Advanced Breast Cancer (LABC) 1Gliosarcoma 1Glioma 1Glioblastoma 1Central Nervous System Neoplasms 1Breast Neoplasms, Male 1Brain Neoplasms 1Astrocytoma 1Adenocarcinoma, Bronchiolo-Alveolar 1

Interventions

Radiotherapy 11Cisplatin 11Radiotherapy, Intensity-Modulated 6Radiation 5Fluorouracil 5Cetuximab 5pembrolizumab 4Carboplatin 3fludarabine phosphate 2fludarabine 2durvalumab 2aldesleukin 2Vorinostat 2Surveys and Questionnaires 2Restraint, Physical 2Psychiatric Rehabilitation 2Polymerase Chain Reaction 2Paclitaxel 2Nivolumab 2Nicotine 2Immunohistochemistry 2Hydroxyurea 2Gene Expression Profiling 2Drug Therapy 2Docetaxel 2Cyclophosphamide 2Counseling 2Celecoxib 2Bupropion 2Blood Specimen Collection 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Oropharyngeal Neoplasms × advexin × Clear all
NCT00064103 2013-01-23

Gene Therapy in Preventing Cancer in Patients With Premalignant Carcinoma of the Oral Cavity or Pharynx

National Cancer Institute (NCI)

Phase 1/2 Completed
51 enrolled
Head & Neck

Mouth Neoplasms, Oropharyngeal Neoplasms, Tongue Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡